Tag: Novartis

  • Drug Companies Paid Doctors To Prescribe Lists

    It is known hat Doctors resort to unethical practices.

    I have posted how a Doctor forced a patient to undergo operations to complete the target and the patient turning up Dead!

    Under Health, I have also listed various unethical practices by the Doctors , Hospitals.

    ProPublica is an independent, non-profit newsroom that produces investigative journalism in the public interest. Our work focuses exclusively on truly important stories, stories with “moral force.” We do this by producing journalism that shines a light on exploitation of the weak by the strong and on the failures of those with power to vindicate the trust placed in them.

    Following is an excerpt from their investigations.

    The next time your doctor prescribes a medicine, recall this and check if the medicine is really needed and will help you.

    Money paid by Drug Companies to Doctors.
    Drug Companies Paid Doctors.

    “When Dollars for Docs first launched in 2010, ProPublica spoke with several of the dozens of doctors who had earned more than $200,000 from their speaking and consulting work for drug companies. Now, with records from more companies and more years of data, we’ve identified 22 doctors who’ve earned at least $500,000 since 2009 — including one, Jon Draud, who was paid more than $1 million.”

    The totals listed here cover different time periods and spending categeories, and aren’t directly comparable. See notes below. See what each company discloses »

    Company Total Disclosed
    AbbVie
    Disclosed: July to Sept. 2012
    $6.9M
    Allergan
    Disclosed: July 2011 to Sept. 2012
    Ranges*
    AstraZeneca
    Disclosed: Jan. 2010 to Sept. 2012
    $236.1M
    Cephalon
    Disclosed: Jan. 2009 to Dec. 2012
    $89.7M
    Eli Lilly
    Disclosed: Jan. 2009 to June 2012
    $490.6M
    EMD Serono
    Disclosed: Jan. 2011 to Sept. 2012
    $4M
    Forest
    Disclosed: Jan. to Sept. 2012
    $60.8M
    GlaxoSmithKline
    Disclosed: April 2009 to Sept. 2012
    $238.6M
    Johnson & Johnson
    Disclosed: Jan. 2010 to Sept. 2012
    $54.6M
    Merck
    Disclosed: July 2009 to Sept. 2012
    $224.3M
    Novartis
    Disclosed: Oct. 2010 to Sept. 2012
    $54.2M
    Pfizer
    Disclosed: July 2009 to Sept. 2012
    $538.2M
    UCB
    Disclosed: Jan. to Sept., 2012
    $7.2M

    Source:

    http://projects.propublica.org/docdollars/

  • Drug Patent Rights India Wins First Round Novartis Full Text

    The instances of Multinationals stealing indigenous medicines is well-known.

    So are the capricious overpricing of life saving Drugs, like Cancer Drugs.

    The Intellectual Property Appellate Board rejected the German drug maker’s appeal of the 2012 ruling on Monday. It also ruled that under the license Natco must pay 7 per cent in royalties on net sales to Bayer.

    Bayer sells a one month supply of the drug for about $5,600. Natco’s version would cost Indian patients $175 a month, less than 1/30th as much.

    Western pharmaceutical companies have been pushing for stronger patent protections in India to regulate the country’s $26 billion US generics industry, which they say frequently flouts intellectual property rights. However, health activists and aid groups counter that Indian generics are a lifesaver for patients in poor countries who cannot afford Western prices to treat diseases such as cancer, malaria and HIV.’

    http://ramanisblog.in/2013/03/23/cancer-drugs-combinations-prices/

    Big Court Ruling Favors Generic Drugs: The Times’s Katie Thomas explains why a ruling in India favoring generic drugs has rippling effects around the world.
    Big Court Ruling Favors Generic Drugs: The Times’s Katie Thomas explains why a ruling in India favoring generic drugs has rippling effects around the world.

    India drew first blood in a Patent case in The Supreme Court .

    Supreme Court , India,Judgement, Novartis Case
    Supreme Court , India,Judgement, Novartis Case

    ‘People in developing countries worldwide will continue to have access to low-cost copycat versions of drugs for diseases like H.I.V. and cancer, at least for a while…

    Production of the generic drugs in India, the world’s biggest provider of cheap medicines, was ensured on Monday in a ruling by the Indian Supreme Court.

    Cost of Glivec used for targeted therapy in CML patients: 1 lakh per month (approx)

    Cost of its generic versions : 8,000 -10 ,000 per month

    No. of cancer centres in India: 450 approx (half are in the private sector)

     

    The debate over global drug pricing is one of the most contentious issues between developed countries and the developing world. While poorer nations maintain they have a moral obligation to make cheaper, generic drugs available to their populations — by limiting patents in some cases — the brand name pharmaceutical companies contend the profits they reap are essential to their ability to develop and manufacture innovative medicines.

    Specifically, the decision allows Indian makers of generic drugs to continue making copycat versions of the drug Gleevec, which is made by Novartis. It is spelled Glivec in Europe and elsewhere. The drug provides such effective treatment for some forms of leukemia that the Food and Drug Administration approved the medicine in the United States in 2001 in record time. The ruling will also help India maintain its role as the world’s most important provider of inexpensive medicines, which is critical in the global fight against deadly diseases. Gleevec, for example, can cost as much as $70,000 a year, while Indian generic versions cost about $2,500 a year.

    The ruling comes at a challenging time for the pharmaceutical industry, which is increasingly looking to emerging markets to compensate for lackluster drug sales in the United States and Europe. At the same time, it is facing other challenges to its patent protections in countries like Argentina, the Philippines, Thailand and Brazil.

    “I think other countries will now be looking at India and saying, ‘Well, hold on a minute — India stuck to its guns,’ ” said Tahir Amin, a director of the Initiative for Medicines, Access and Knowledge, a group based in New York that works on patent cases to foster access to drugs.

    In trade agreements — including one being negotiated between the United States and countries in the Pacific Rim — the drug industry has lobbied for stricter patent restrictions that would more closely resemble protections in the United States.

    http://www.nytimes.com/2013/04/02/business/global/top-court-in-india-rejects-novartis-drug-patent.html?nl=todaysheadlines&emc=edit_ae_20130401&_r=0

    Full Text of The Judgement.

    http://www.scribd.com/doc/133345899&#8243

  • Novartis To Pay $ 78 Millions, Retracts, Hiding Secrets

    Swiss pharmaceutical company Novartis was to pay its outgoing chairman $78 million for a six-year consulting and non-compete agreement.

    In plain English it wanted to pay the amount to prevent him leaking Company Secrets.

    But after severe criticisms all around both changed their minds.

    If you can pay $ 78 Million Dollars, rightly called more than evil,imagine how much you have swindled and are swindling consumers.!

    I will be posting a blog on Cancer medicines cost details.

    My readers, specially who are Doctors,may kindly forward information to me at my email.

    No longer! Now both the company and chairman Daniel Vasella have changed their minds.

    “I have understood that many people in Switzerland find the amount of the compensation linked to the non-compete agreement unreasonably high, despite the fact I had announced my intention to make the net amount available for philanthropic activities,” said Vasella, who was CEO of Novartis from 1996 to 2010, after which he became board chairman.

    That’s largely because of the uproar that followed after the New York Times reported the “golden handshake” deal on Monday. The amount was “beyond evil,” according to Christophe Darbellay, president of the Christian Democratic Popele’s Party, as a Swiss federal judge found the sum to be an “enormous blow for the social cohesion of our country.”

    Novartis.
    Novartis.

    The timing on this was pretty bad. Vasella has “long [been] a lightening rod for criticism of executive pay in Switzerland,” reports Reuters. And on Friday, Novartis will hold its general meeting with shareholders. More critically, though, in two weeks, Switzerland will vote on a referendum to give shareholders decision-making power over executive pay. If the March 3 referendum passes, the heads of companies like Novartis, Roche and Nestle could see their compensation set by shareholders. Though other countries have non-binding “say on pay” laws, Switzerland would be the first country to enforce shareholder decisions (paywall).(qz.com)

    http://qz.com/55008/novartis-wanted-to-pay-an-exec-78-million-to-keep-secrets-that-dont-exist/

    Look at Novartis Compensation package here.

    Base compensation

    Each associate is given a fixed salary based on job characteristics, market competitiveness and the associate’s skills. Salary growth depends on the associate’s individual performance and level compared to the benchmark.

    Variable compensation

    Novartis Group companies have three variable compensation plans:

    Short-Term Incentive Plans
    Awards under the short-term incentive plans are made each year based on the associate’s individual target incentive percentage, individual year-end performance rating as well as on the Group’s or business area’s performance.

    Associates in certain countries and certain key executives worldwide are encouraged to receive their annual incentive awards fully or partially in Novartis shares instead of cash by participating in a leveraged share savings plan.

    Novartis Equity Plan “Select”
    Each year, approximately 10 percent of all full-time-equivalent associates worldwide may be eligible for a grant under the Equity Plan “Select”. Grants can be taken in the form of restricted shares, tradable share options or a combination of both, with a vesting period of three years. In some jurisdictions Restricted Share Units (RSU) are granted rather than shares.

    Long-Term Performance Plan
    The Novartis Long-Term Performance Plan rewards key executives who have a significant impact on the long-term success of the Group by aligning the incentives of key executives to the performance of Novartis.

    Benefits

    Novartis benefits programs are an integral part of the total compensation policy and strategy and are designed to meet the challenges of the growing, global competition for talent.

    These programs support the overall business objectives and strategy of Novartis. Benefits are aligned with local legislation and practices in each country and are established to provide a framework of security for associates.

    http://www.novartis.com/careers/compensation-benefits/index.shtml

    http://www.iaeste.ch/Trainees/Events/2008/IndustrialSightNovartis/

  • Modified Apple Triggers Virulent New Virus diseases .

    Playing with Nature ,especially with Plants,Food shall have disastrous consequences.

    Monsanto seems to be doing this with impunity.

    Government looks on.

    Best way to stop Corporates in their tracks is to ignore the Product .

    Apples, once the darling of nutrition, have become genetically modified (GMO) to increase production, sales and profits. The once formidable addition to our diets has become a shadow of its former self because apples no longer have the nutritional value of their chemical-free predecessors.

    Some scientists opine that GMO apples have 76% less nutritional value than the chemical-free, organic version of the same food. A chemical-free, natural organic apple has significantly higher levels of all 21 nutrients analyzed compared with genetically modified fruits including vitamin C (27% more), magnesium (29% more), iron (21% more) and phosphorous (14% more).

    How did a treasured American fruit become not only tasteless but harmful to children and adults alike? It is because the food industry uses the Cauliflower Mosaic Virus (CaMV) as a “gene promoter” to create these new apples.

    The apple seed is split with the virus so that a pesticide gene can be inserted to kill insects. The pesticide causes the stomachs of insects to explode.

    The Cauliflower Mosaic Virus is used because it is a powerful virus that cannot be destroyed during gene splitting. It is a retro-virus that alters the RNA, that causes changes in the DNA, resulting in similar viruses that ultimately become HIV, Leukemia Virus and hepatitis B. This is a very dangerous virus. Industry scientists ignore the axiom, “If you play with fire, you get burned.”

    The virus is found in every cell of the DNA and RNA of the GMO apple and the residue in the apples stays in your gut and leads to Crohn’s disease, IBD and IBS.

    Dr. Daniel C. Dantini, a noted expert on the topic of food allergies and intolerance, opines that, “Any virus, bacteria, parasite, or yeast can inflame the intestine.” This will lead to immune problems within the body, inflammation and even include delayed food allergies.

    It also produces “more virulent new virus diseases . . . CaMV viruses may also incorporate genes from the host plant creating virulent new diseases”. Professor Joe Cummins made it clear that there is still a statistical risk involved for the creation of a dangerous virus. Much like a sci-fi film, it is another “mad scientist” playing with fire. From Frankenstein to Swamp Thing, films and literature are filled with these types of experiments gone bad.

    According to author and expert, Jeffrey M. Smith, “This means that long after we stop eating GMOs [apples], we may still have potentially harmful GM proteins produced continuously inside of us.”

    Sadly, genetically modified apples are further contaminated by the need for the farmer to use multiple applications of pesticides. More than 400 chemical pesticides are regularly used in genetic farming to kill weeds, insects and other pests. If that number frightens you, consider this: non-organic apples are routinely sprayed up to 16 times with 36 different pesticides before being picked. Then the apples are sprayed with ethylene and covered with wax to make them look prettier.

    In addition, Big Food scientists even field tested chicken genes in apples. Chicken genes? What were they trying to do? Get the apples to sprout wings and fly to the market to save shipping costs? Make no mistake about it, these are not the apples your grandparents ate every day. Nor the “one a day keeps the doctor away” apples that doctors recommend.

    As a result, Americans are eating an abnormal, adulterated copies of natural organic apples (modified by a “mad scientist” in a lab) soaked in pesticides and sprayed with chemicals. Do you really want to feed an adulterated apple to your child?

    If you feed your child an apple a day, it will not keep the doctor away. On the contrary, a child will be exposed to more viruses, the possibility of childhood illness and disease, weight gain and obesity. Adults fare no better eating a genetically modified chemically soaked apple a day.

    For expectant mothers, these are the types of foods that lead to chemically altering the DNA of a fetus and/or starting that fetus down the road to childhood diseases. Just look at the growing statistics on childhood illnesses to validate the problem. Is this what we want in our society – chemical garbage instead of the “real thing”? Do we really want to make our children chemical dump sites for Big Food?

    Johnny Appleseed lived by the Golden Rule as he planted the seeds of apples in the United States. He remained connected to nature and mankind through his deeply religious values. He was known to have no fear of man or beast.

    One can only wonder how sad he would be to realize that the beast within man could destroy those beautiful seeds and have no conscious about harming others. What ever happened to that Golden Rule? Johnny Appleseed must be turning over in his grave.

    This is why the nutritional value of GMO apples are negligible. Anything that increases the number of harmful chemicals in your body should be avoided.  Any fruit that can alter your DNA and RNA and leave bacterias and viruses in your intestines should be banned from public consumption.

    The food industry scientists are rolling the dice with peoples’ lives. If they roll the dice long enough, society will lose. That loss is already measured by the increase in diabetes, cancer, kidney and liver failure and the long line of Americans waiting for kidney and liver transplants.

    None of this happened before scientists created genetically modified foods and more than 9,000 addictive chemicals now used in our food supply.

    Mannie Barling and Ashley F. Brooks, R.N., are the authors of award winning books – Arthritis, Inflammation, Gout, Crohn’s, IBD and IBS – How to Eliminate Pain and Extend your Life (Books and Authors 2010 Best Books in the Health, Diet & Reference Categories) and Mannie’s Diet and Enzyme Formula – A Change of Lifestyle Diet Designed for Everyone (Blogger News Net 2010 Best Health And Nutrition Book Award winner) available at HowToEliminatePain.com, Amazon, Barnes&Noble, and other booksellers around the world.

    http://www.bloggernews.net/125881

    The industry marketing pitch to the public is that bioengineered seeds and plants will help the environment by reducing toxic herbicide/pesticide use. Isolated examples are given, but the overall reality is exactly opposite. The majority of GM agricultural products are developed specifically for toxin-resistance ~ namely for higher doses of herbicides/ pesticides sold by the largest producer companies ~ Monsanto, Dupont Novaris, Dow, Bayer, Ciba-Geigy, Hoescht, AgroEvo, and Rhone-Poulenc.

    http://musicians4freedom.com/2010/12/30/harmful-effects-of-genetically-modified-foods/